![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IFT20 |
Gene summary for IFT20 |
![]() |
Gene information | Species | Human | Gene symbol | IFT20 | Gene ID | 90410 |
Gene name | intraflagellar transport 20 | |
Gene Alias | IFT20 | |
Cytomap | 17q11.2 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q8IY31 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
90410 | IFT20 | LZE8T | Human | Esophagus | ESCC | 1.31e-07 | 2.04e-01 | 0.067 |
90410 | IFT20 | LZE20T | Human | Esophagus | ESCC | 3.27e-03 | 6.48e-02 | 0.0662 |
90410 | IFT20 | LZE22D1 | Human | Esophagus | HGIN | 3.56e-03 | 9.44e-02 | 0.0595 |
90410 | IFT20 | LZE22T | Human | Esophagus | ESCC | 6.50e-03 | 3.22e-01 | 0.068 |
90410 | IFT20 | LZE24T | Human | Esophagus | ESCC | 3.12e-33 | 9.63e-01 | 0.0596 |
90410 | IFT20 | LZE6T | Human | Esophagus | ESCC | 3.15e-05 | 3.73e-01 | 0.0845 |
90410 | IFT20 | P1T-E | Human | Esophagus | ESCC | 1.74e-11 | 6.45e-01 | 0.0875 |
90410 | IFT20 | P2T-E | Human | Esophagus | ESCC | 1.15e-25 | 3.98e-01 | 0.1177 |
90410 | IFT20 | P4T-E | Human | Esophagus | ESCC | 3.30e-35 | 6.77e-01 | 0.1323 |
90410 | IFT20 | P5T-E | Human | Esophagus | ESCC | 8.97e-11 | 2.84e-01 | 0.1327 |
90410 | IFT20 | P8T-E | Human | Esophagus | ESCC | 2.80e-35 | 6.99e-01 | 0.0889 |
90410 | IFT20 | P9T-E | Human | Esophagus | ESCC | 1.16e-22 | 5.36e-01 | 0.1131 |
90410 | IFT20 | P10T-E | Human | Esophagus | ESCC | 1.39e-51 | 9.31e-01 | 0.116 |
90410 | IFT20 | P11T-E | Human | Esophagus | ESCC | 1.80e-18 | 5.73e-01 | 0.1426 |
90410 | IFT20 | P12T-E | Human | Esophagus | ESCC | 1.93e-24 | 5.31e-01 | 0.1122 |
90410 | IFT20 | P15T-E | Human | Esophagus | ESCC | 1.38e-20 | 4.09e-01 | 0.1149 |
90410 | IFT20 | P16T-E | Human | Esophagus | ESCC | 1.58e-19 | 3.36e-01 | 0.1153 |
90410 | IFT20 | P17T-E | Human | Esophagus | ESCC | 3.06e-10 | 2.72e-01 | 0.1278 |
90410 | IFT20 | P19T-E | Human | Esophagus | ESCC | 3.66e-08 | 8.95e-01 | 0.1662 |
90410 | IFT20 | P20T-E | Human | Esophagus | ESCC | 1.83e-17 | 3.60e-01 | 0.1124 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000931412 | Breast | IDC | response to radiation | 62/1434 | 456/18723 | 6.91e-06 | 2.10e-04 | 62 |
GO:000716314 | Breast | IDC | establishment or maintenance of cell polarity | 32/1434 | 218/18723 | 2.84e-04 | 4.33e-03 | 32 |
GO:006053711 | Breast | IDC | muscle tissue development | 50/1434 | 403/18723 | 4.91e-04 | 6.45e-03 | 50 |
GO:00147061 | Breast | IDC | striated muscle tissue development | 46/1434 | 384/18723 | 1.67e-03 | 1.63e-02 | 46 |
GO:00426923 | Breast | IDC | muscle cell differentiation | 44/1434 | 384/18723 | 4.77e-03 | 3.66e-02 | 44 |
GO:00511463 | Breast | IDC | striated muscle cell differentiation | 34/1434 | 283/18723 | 6.00e-03 | 4.31e-02 | 34 |
GO:00726599 | Breast | IDC | protein localization to plasma membrane | 34/1434 | 284/18723 | 6.33e-03 | 4.47e-02 | 34 |
GO:00016555 | Breast | IDC | urogenital system development | 39/1434 | 338/18723 | 6.75e-03 | 4.68e-02 | 39 |
GO:000931422 | Breast | DCIS | response to radiation | 62/1390 | 456/18723 | 2.56e-06 | 8.87e-05 | 62 |
GO:000716324 | Breast | DCIS | establishment or maintenance of cell polarity | 32/1390 | 218/18723 | 1.62e-04 | 2.71e-03 | 32 |
GO:006053721 | Breast | DCIS | muscle tissue development | 50/1390 | 403/18723 | 2.39e-04 | 3.74e-03 | 50 |
GO:00147062 | Breast | DCIS | striated muscle tissue development | 46/1390 | 384/18723 | 8.88e-04 | 1.01e-02 | 46 |
GO:004269211 | Breast | DCIS | muscle cell differentiation | 43/1390 | 384/18723 | 4.56e-03 | 3.49e-02 | 43 |
GO:005114611 | Breast | DCIS | striated muscle cell differentiation | 33/1390 | 283/18723 | 6.63e-03 | 4.62e-02 | 33 |
GO:001623616 | Esophagus | HGIN | macroautophagy | 77/2587 | 291/18723 | 7.15e-09 | 4.61e-07 | 77 |
GO:007265920 | Esophagus | HGIN | protein localization to plasma membrane | 66/2587 | 284/18723 | 1.11e-05 | 3.18e-04 | 66 |
GO:19021156 | Esophagus | HGIN | regulation of organelle assembly | 46/2587 | 186/18723 | 4.63e-05 | 1.12e-03 | 46 |
GO:00070336 | Esophagus | HGIN | vacuole organization | 44/2587 | 180/18723 | 8.97e-05 | 1.96e-03 | 44 |
GO:199077818 | Esophagus | HGIN | protein localization to cell periphery | 71/2587 | 333/18723 | 1.05e-04 | 2.24e-03 | 71 |
GO:00315035 | Esophagus | HGIN | protein-containing complex localization | 50/2587 | 220/18723 | 2.18e-04 | 3.98e-03 | 50 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IFT20 | SNV | Missense_Mutation | c.152N>T | p.Glu51Val | p.E51V | Q8IY31 | protein_coding | deleterious(0.01) | probably_damaging(0.914) | TCGA-E9-A22E-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphane | SD | |
IFT20 | insertion | In_Frame_Ins | novel | c.190_191insTGAAAGGGTCCACGAAGTTGGCTGGCTCTCTGAAAG | p.Lys64delinsMetLysGlySerThrLysLeuAlaGlySerLeuLysGlu | p.K64delinsMKGSTKLAGSLKE | Q8IY31 | protein_coding | TCGA-B6-A0IK-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | ||
IFT20 | SNV | Missense_Mutation | novel | c.247N>T | p.Leu83Phe | p.L83F | Q8IY31 | protein_coding | deleterious(0.01) | possibly_damaging(0.51) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
IFT20 | SNV | Missense_Mutation | c.341N>A | p.Ala114Asp | p.A114D | Q8IY31 | protein_coding | tolerated(0.05) | possibly_damaging(0.857) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
IFT20 | SNV | Missense_Mutation | rs372746932 | c.401N>A | p.Arg134Gln | p.R134Q | Q8IY31 | protein_coding | tolerated(0.11) | benign(0.169) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
IFT20 | SNV | Missense_Mutation | novel | c.80N>C | p.Met27Thr | p.M27T | Q8IY31 | protein_coding | deleterious(0) | benign(0.023) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IFT20 | SNV | Missense_Mutation | novel | c.81N>A | p.Met27Ile | p.M27I | Q8IY31 | protein_coding | deleterious(0.03) | benign(0.013) | TCGA-86-7954-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | CR |
IFT20 | SNV | Missense_Mutation | novel | c.281A>G | p.Glu94Gly | p.E94G | Q8IY31 | protein_coding | deleterious(0) | probably_damaging(0.967) | TCGA-MN-A4N4-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |